APPENDIX 8
Memorandum from the WWF
EXECUTIVE SUMMARY
WWF, the global environment network
works at the cutting edge of research into global chemical contamination
and is a well-respected not-for-profit organisation working on
chemicals policy in Europe.
Humans and animals the world over
the have been exposed to man-made industrial or agricultural chemicals
and there is ever increasing evidence to suggest that certain
hazardous man-made chemicals have been linked to a rising rate
in certain cancers, birth defects, genital deformities, reproductive
problems and effects on children's brain development and immune
systems.
In order to secure the objective
of protecting human health and the environment, it is vital that
exposure to chemicals of very high concern are eliminated, wherever
possible. Therefore, WWF considers that the use of chemicals of
very high concern, including very persistent and very bioaccumulative
chemicals and endocrine disrupting chemicals, should only be authorised
when there is a no safer alternative, and an overwhelming societal
need, and measures to minimise exposure are in place. WWF considers
that the availability of a safer substitute should, by itself,
be grounds for the regulators to refuse to authorise the use of
such chemicals.
Failure to ensure the substitution
of chemicals of high concern would mean that humans and wildlife
would continue to be exposed to hazardous man-made chemicals and
would not deliver a move away from the worst chemicals, nor stimulate
the innovation of safer alternatives. Therefore, the costs of
the new system would be incurred without achieving the benefit
of reducing the risks that these chemicals of very high concern
pose to human health or the environment. Moreover, because innovation
would not be encouraged, the EU would not be well placed to reap
a growing share of the world market for greener products and safer
alternatives.
WWF does not believe that it should
be necessary to prove that serious and irreversible effects are
caused by chemicals meeting the criteria for very high concern,
before action is taken to eliminate exposure. These chemicals
are clearly undesirable, without having to conduct many animal
tests to elucidate fully their toxicity. The fact that the unborn
child is particularly at risk from these chemicals, supports a
precautionary approach.
Industry should be required to provide
sufficient toxicity data on their chemicals in order to enable
good risk management decisions to be taken, with regard to both
environmental and human health.
WWF considers that Member States
should be given a mandatory duty to carry out a minimum annual
number of evaluations of the substance safety assessments provided
by industry on its chemicals. This would enhance quality control,
the prioritisation and review of problematic substances, and would
also ensure that the Member States' authorities have the resources
for this important work.
WWF recommends that all authorisations
should be time-limited, and subject to review at least every five
years.
WWF believes that importers should
have the duty to ensure that all the chemicals in articles/ products
they import comply with any restrictions on use and are registered
in the EU. If not, then they (or their supplier) should apply
to register the chemicals contained in them. Failure to do so
will mean that there is a continued risk to our health and the
environment and the competitiveness of specific industry sectors.
WWF considers it vital that an independent
mandatory evaluation of the quality and content of the registration
dossiers is required in order to ensure the accuracy of registration
dossiers.
WWF believe that data sharing must
be made compulsory to ensure duplicate animal testing is avoided.
Public access to all toxicity, fate,
exposure, use categories, and risk assessment data should be ensured.
WWF supports prioritisation in that
chemicals that are known to meet the criteria for very high concern
should be brought into registration in the first tranche. In addition,
WWF considers that there should be prioritisation to ensure that
the worst chemicals that have undergone registration are evaluated
as a priority, and to ensure that the worst chemicals of very
high concern go through to the prior authorisation process first.
However, WWF does not support a risk-based prioritisation process
to queue chemicals into the REACH registration process, or indeed,
to determine which chemicals should be brought under the registration
process at all.
WWF rejects the argument that REACH
will be economically damaging and believes that there is no evidence
to suggest that increasing environmental constraints have either
slowed overall growth rates or disadvantaged certain countries
economically. In addition, research has shown that there is little
evidence to suggest that environmental regulations have significant
effects on employment.
WWF believes that the REACH Regulation
will bring many benefits to business, including new markets for
safer and more environmentally friendly products, reduced risk
of future liability lawsuits, easier introduction of new chemicals,
a more predictable regulatory system, and improved transparency
and communication through the supply chain, leading to increased
influence and confidence for downstream users and SMEs.
In addition, the REACH Regulation
will provide health benefits both for the public at large and
for workers. Chemical substances are considered to play a major
role in inducing allergies, and have been linked with occupationally
caused cancer and work related skin disease. In October 2003,
the Commission published an impact assessment of its new draft
text, which reported that the estimated total current worst case
costs of REACH, both for producers and downstream users, are 5.2
billion euros spread over 10 years, whilst the health benefits
are roughly estimated to be around 50 billion euros over 30 years.
Professor David Pearce, in a report commissioned by WWF, suggests
that the value of the health benefits could be far higher, and
easily exceed 100 billion euros.
The UK government should be leading
the way by supporting a robust Chemical Regulation, which protects
future generations of humans and wildlife. A regulation, which
encourages phase out of the most hazardous chemicals will be good,
not only for humans and wildlife, but for business and innovation
too. It will provide an improved framework for innovation in the
chemicals sector, and contribute to the development of green chemicals.
It could strengthen the competitiveness of the chemicals industry
and provide new markets for safer and more environmentally friendly
products. This is a key chance for the UK Government to promote
the development of our chemicals industry and to grasp this opportunity
for greater innovation, competitiveness and consumer choice.
In future, we therefore urge the
UK Government:
to prioritise the needs of public
health, our wildlife and the environment;
to recognise the business, health
and environmental benefits of the EU Chemical Regulation;
to commit clearly to a robust
Chemical Regulation, which incorporates the substitution principle
and phases out the most harmful chemicals where safer alternatives
exist; and
use its leverage within the EU
to push other key member states to support a similarly robust
position.
INTRODUCTION
Humans and animals all over the world have been
exposed to man-made industrial or agricultural chemicals. There
is now unequivocal evidence that chemicals have already caused
serious damage to the health of wildlife. Moreover, there is ever
increasing evidence to suggest that certain hazardous man-made
chemicals have been linked to a rising rate in certain cancers,
birth defects, genital deformities, reproductive problems and
effects on children's brain development and immune systems. However,
the full extent of the problem is unclear because adequate toxicity
data are only available for a small percentage of the many thousands
of chemicals in everyday industrial and domestic use.
WWF is uniquely well place to provide expert
opinion and analysis on this global problem. For well over 10
years, WWF has led the way in cutting edge research on chemicals
and was one of the first organisations to publish evidence of
the pervasive and global problem of chemical contamination. Earlier
in 2003, WWF in association with the WI and The Co-operative Bank,
launched a Chemicals and Health Campaign which is calling for
very hazardous man-made chemicals, that is, chemicals of very
high concern, to be properly regulated, and replaced where safer
alternatives exist.
WWF believes that the REACH proposal for the
reform of EU chemicals legislation has the potential to make a
significant contribution to sustainable development. REACH could
ensure a high standard of protection of human health and the environment,
whilst simultaneously encouraging innovation towards safer and
greener products. However, WWF considers that the Commission's
proposal needs to be significantly improved to achieve these aims.
Therefore, WWF welcomes this opportunity to comment on this timely
Science and Technology Committee Inquiry into the EU Chemical
Regulation.
Part 1 of this briefing outlines the key amendments
that in WWF's opinion need to be made to the current draft of
the EU "REACH" regulation. As requested, these are documented
in WWF's order of priority. In order not to loose clarity, minor
additional amendments, which would need to be made elsewhere in
the proposed text to ensure consistency with these proposals,
have not been addressed in this document. Extracts of the draft
REACH legislation are shown in boxes with suggested amendments
in bold. A resume is also provided of the consequences that would
result, were these key amendments not made.
Part 2 comments on two other topical issues,
namely prioritization, and the costs and benefits of the regulation.
Part 3 outlines the role played by the UK Government, and what
actions need to be taken by the UK Government, in the final stages
of the legislative process.
WWF'S PRIORITY
AMENDMENTS
1. CLEAR
PREFERENCE SHOULD
BE GIVEN
TO SUBSTITUTION
RATHER THAN
CONTROL TECHNIQUES
In order to secure the objective of protecting
human health and the environment, it is vital that exposures to
chemicals of very high concern are eliminated, wherever possible.
And the best way to ensure exposures are eliminated, is to substitute
the chemical of very high concern with a safer alternative. Therefore,
WWF considers that the use of chemicals of very high concern should
only be authorised when there is a no safer alternative, and an
overwhelming societal need, and measures to minimise exposure
are in place. Thus, WWF considers that the availability[3]
of a safer substitute should, by itself, be grounds for the regulators
to refuse to authorise the use of such chemicals. A safer substitute
would be one that was judged not to meet the criteria for chemicals
of very high concern and which had an acceptable acute toxicity
profile.
It is very difficult to ensure chemicals are
properly controlled during their entire life cycle, and even good
control measures can result in appreciable exposures. The aim
must be to eliminate exposure to substances of very high concern,
because for many of these substances, such as carcinogens, there
may be no safe level. Moreover, for persistent and bioaccumulative
chemicals, and endocrine disrupting chemicals, there may be additive
effects due to the total burden of exposure to harmful chemicals.
Therefore, there is a clear case for measures that seek to eliminate,
rather than to control, exposure. This can be best delivered by
substitution, and although substitution was one of the stated
central objectives of the Commission's White Paper,[4]
the European Parliament,[5]
and the EU Council of Ministers,[6]
it still needs to be given more prominence in the legislation.
Therefore WWF suggests that the following amendment
should be made:
Article 52 of the draft legislation states that
"The aim of this Title is to ensure the
good functioning of the single market whilst assuring that the
risks from substances of very high concern are properly controlled
or that these substances are replaced by suitable alternative
substances or technologies."
Replace with
"The aim of this Title is to ensure that
substances of very high concern are replaced by suitable alternative
substances or technologies where available, or that such alternatives
are developed where they are not already available."
2. AUTHORISATIONS
SHOULD ONLY
BE GRANTED
WHEN THERE
IS NO
SAFER ALTERNATIVE,
AN OVER-WHELMING
SOCIETAL NEED
FOR THE
CHEMICAL EXISTS,
AND MEASURES
TO MINIMISE
EXPOSURE ARE
IN PLACE.
THE AVAILABILITY
OF A
SAFER ALTERNATIVE
ALONE SHOULD
THEREFORE BE
GROUNDS TO
REFUSE AUTHORISATION
WWF is very concerned about the process for
granting an authorisation. The draft legislation continues to
allow industry to carry on using (gain an authorisation for) chemicals
of very high concern. Industry can either claim an adequate control
of the risk or if they can't do that, then an authorisation can
still be granted if the socio-economic benefits outweigh the risks.
The chemicals that require prior authorisation
are deemed to be chemicals of very high concern because they possess
certain intrinsic properties. They include PBTs (persistent bioaccumulative
and toxic substances), vPvBs (very persistent and very bioaccumulative
substances), CMR 1 & 2s (carcinogens, mutagens and chemicals
that are toxic to reproduction), EDCs (endocrine disrupting chemicals)
and other chemicals of equivalent concern. WWF is concerned that
if the Commission accept industry's arguments that the risks of
such chemicals are adequately controlled, they must authorise
the use of the chemical, even if a safer alternative is readily
available. This will not drive substitution.
Annex 1, section 6 gives an indication of what
adequate control of the risk may mean for PBT and vPvB chemicals.
This outlines that for these chemicals, risk management measures
that "minimise exposures" are needed [6.5]. However,
even small exposures to bioaccumulative chemicals can lead to
the chemical building up over time, and unforeseen exposures have
often occurred in the past. The presence of chlorinated paraffins,
brominated flame retardants, synthetic musks and numerous other
man-made chemicals in human body fat, bear testimony to this.
PBT and vPvB chemicals may also eventually leach from landfill
sites, such that it is difficult if not impossible to contain
exposures over the cradle to grave life-cycle. It would certainly
be better to substitute carcinogens for safer chemicals, as it
is widely recognised that for some carcinogens there may be no
safe level of exposure. Similarly, for chemicals with endocrine
disrupting properties, these chemicals modulate a biological system
that is already active, such that even small amounts may have
effects.
Therefore, WWF considers that the intrinsic
properties of the chemicals that are designated as chemicals of
very high concern, means that the risks cannot be adequately controlled,
unless exposure is eliminated. This can only reliably be achieved
by stopping the use of such chemicals, and using safer alternatives
instead.
In cases where suitable alternatives do not
currently exist, and the socio-economic benefit accrued to society
genuinely outweigh the risks, then WWF considers that a time limited
authorisation could be granted, albeit linked with a timetabled
substitution plan. Such a strategy, for example, would allow the
use of a persistent and bioaccumulative (fictitious) composite
material in a false hip-joint that brought mobility to thousands
of elderly people, but would not allow it to be used in plastic
storage boxes. In other words, where there is a robust case for
the continued use of substances of very high concern, based on
socio-economic benefit and unavailability of suitable alternatives,
the option clearly remains for authorisation to be granted. In
this way, truly essential uses of these substances will not be
prevented. Thus, WWF proposes that there should be only one route
for obtaining an authorisation.
Failure to encourage the substitution of chemicals
of high concern would neither ensure a move away from the worst
chemicals, nor would it stimulate the innovation of safer alternatives.
Therefore, the costs of the new system would be incurred without
achieving the benefit of reducing the risks that these chemicals
of very high concern pose to human health or the environment.
Moreover, because innovation would not be encouraged, the EU would
not be well placed to reap a growing share of the world market
for greener products and safer alternatives.
In addition, allowing industry to argue that
the risks were adequately controlled, could either result in the
system floundering under a very time consuming risk assessment
process, or it could potentially result in chemicals being authorised
without adequate investigation of the case made by industry.
It should be recognised that the slow progress
of the existing regulation 793/93 was one of the main reasons
that the new REACH legislation was proposed. There is therefore
a need to cut short discussions on what is an "adequate control
of the risks". For example, past experience with the risk
assessment process under the current legislation, suggests that
what industry considers to be "adequate control of the risk"
may fall below the necessary level of health and environmental
protection. For example, in the past, when regulatory controls
have been on the horizon under the Existing Substances Regulation,
industry has claimed that its products are safe for use. Take
the case of penta-BDE, a brominated flame retardant chemical,
found as a contaminant in breast milk in Europe and the USA. The
regulatory authorities commenced the risk assessment of this chemical
in the late 1990s. But industry would not accept that there was
any need for concern. In October 1999, industry submitted a paper
stating that when the whole breast milk issue was put into perspective,
the only rational and scientific conclusion was that there was
no need for further information and/or testing and no need for
any more risk reduction measures.[7]
In contrast to this, the EU authorities subsequently decided that
a ban was needed.[8]
Therefore, in order to short circuit tortuous discussions on what
is an `adequate' control of the risk, in WWF's view, if safer
alternatives are available then industry should have to use them.
After all, we are talking about the worst chemicals, so surely
this no more than common sense.
Therefore WWF believes that Article 57 paragraphs
2 and 3, should be replaced as detailed in the following:
Article 57, relating to authorisations, states:
"An authorisation shall be granted if the
risk to human health or the environment from the use of a substance
arising from the intrinsic properties specified in Annex XIII
is adequately controlled in accordance with Annex 1, section 6,
and as documented in the applicant's chemical safety report.
The Commission shall not consider the following:
risks to human health and the environment
of emissions of the substance from an installation for which a
permit was granted in accordance with Council Directive 96/61/EC
(our insert = the IPPC Directive);
risks to and via the aquatic environment
of discharges of the substance from a point source governed by
the requirement for prior regulation referred to in . . . Directive
2000/60/EC . . . (our insert = the );
risks to human health arising from
the use of a substance in a medical device . . .
If an authorisation cannot be granted under
paragraph 2, an authorisation may be granted if it is shown that
the socio-economic benefits outweigh the risk to human health
or the environment arising from the use of the substance and if
there are no suitable alternative substances or technologies.
This decision shall be taken after consideration
of all the following elements:
the risks posed by the uses of the
substance;
the socio-economic benefits arising
from its use and the socio-economic implications of a refusal
to authorise . . .
the analysis of the alternatives
submitted by the applicant . . . and any third party contributions
. . .
available information on the health
or environmental risks of any alternative substances or technologies."
Suggested replacement
"An authorisation may be granted only if
there are no suitable alternative substances or technologies,
and if it is shown that the socio-economic benefits outweigh the
risk to human health or the environment arising from the use of
the substance, and if measures to minimise exposure are put in
place.
This decision shall be taken after consideration
of all the following elements;
the risks posed by the uses of the
substance;
the socio-economic benefits arising
from its use and the socio-economic implications of a refusal
to authorise . . .
The analysis of alternatives submitted
by the applicant . . . and any third party contributions . . .
Available information on the . .
. risks of any alternative substances or technologies."
3. SUBSTANCES
TO BE
INCLUDED IN
THE AUTHORISATION
PROCESSSHOULD
NOT NEED
TO BE
SHOWN TO
GIVE RISE
TO SERIOUS
AND IRREVERSIBLE
EFFECTS
WWF is pleased that category 1 and 2 CMRs and
PBT and vPvB chemicals are to be brought under the authorisation
process. However, in an alarming move initiated by the Commission
in the final days before the draft text was released, an addition
was made to the draft text which stipulates that there is a need
to show serious and irreversible effects before a chemical of
equivalent concern could be brought under the authorisation process.
WWF believes that there is a need to act on
very persistent and very bioaccumulative chemicals, irrespective
of currently known toxicity. This is because if effects do come
to light, it is impossible to eliminate continued exposure to
these chemicals once they have accumulated in humans or in wildlife.
Moreover, these chemicals pose a particular threat to the unborn,
because once they have accumulated in an animal, they can be transported
to the next generation via the placenta or via the egg. It should
therefore be unnecessary to prove such chemicals are causing serious
and irreversible effects before action is taken to eliminate exposure.
These chemicals are clearly undesirable, without having to conduct
many animal tests to elucidate their toxicity. Moreover, even
if tests on rodents were undertaken, and such chemicals were not
found to be harmful at the levels found in humans, it would still
be difficult to justify the continued exposure of babies in the
womb and breast-fed babies and wildlife. This is because current
toxicity tests only cover a small subset of possible toxicity
concerns, and making reliable extrapolations from relatively short-term
tests on rodents to the long-term effects that may become apparent
in long-lived species exposed to low levels is particularly difficult.
The fact that the unborn child is potentially at risk from these
chemicals, argues for a precautionary approach.
Unless a precautionary approach is taken it
is likely that several thousands of mammals will be used unnecessarily
in laboratory experiments, in order to try to show that these
chemicals do not give rise to toxicity concerns. At worst, it
could result in the continued use of bioaccumulative chemicals,
and hence the continued exposure of the unborn to chemicals that,
in the fullness of time, are found to cause effects which were
not detected in current toxicity testing regimes.
Therefore WWF believes that the Article 54(f)
should be amended as follows:
(f) substances, such as those having endocrine
disrupting properties or those having persistent, bioaccumulative
and toxic properties or very persistent and very bioaccumulative
properties, which do not fulfil the criteria of points (d) and
(e) and which are identified as causing serious and irreversible
effects to humans or the environment which are equivalent to those
of giving rise to a similar level of concern as other substances
listed in points (a) to (e) on a case-by-case basis in accordance
with the procedure set out in Article 56."
4. ENSURE
AN ADEQUATE
NUMBER OF
SUBSTANCE EVALUATIONS
ARE UNDERTAKEN
WWF is concerned that the present text would
allow some countries to undertake no evaluations at all. It is
proposed that the Chemicals Agency will develop guidance on prioritisation
of substances for evaluation. However, at present there is no
minimum number of substance evaluations that must be undertaken.
WWF considers that Member States should be required
to carry out a minimum annual number of evaluations of the safety
data and assessments provided by industry on chemicals. This would
enhance quality control, the prioritisation and review of problematic
substances, and would also ensure that the Member States' authorities
have the resources for this important work.
Therefore, WWF proposes the following addition
to Article 43a (Criteria for substance evaluation):
. . . Member States shall use these criteria
for preparing their rolling plans.
"The agency shall also determine a minimum
number of substance evaluations which should be performed per
annum in order to assist in the identification of substances requiring
further examination or action. The Agency shall use this minimum
figure to calculate appropriate minimum targets for individual
Member States. Each Member State shall carry out, at a minimum,
this target number of Substance Evaluations."
In addition, to ensure that Member States can
decide to do a substance evaluation if new information emerges,
the following should be added at the end of Article 43a bis:
A Member State may at any time add new substance(s)
to their rolling plan should information emerge which leads to
a concern regarding risk to human health and the environment.
They must notify the Agency of their intention to add the substance
to their rolling plan. Should more than one Member State notify
the agency regarding the same substance, the first Member State
to notify the Agency should be appointed to evaluate the substance.
5. ALL
AUTHORISATIONS FOR
USE SHOULD
BE SUBJECT
TO REVIEW
WWF recommends that all authorisations should
be time-limited, and subject to review at least every five years.
In order for the authorisation requirement to adapt to technical
progress, it will be essential for all authorised uses to be subject
to a review period, ie a predetermined period after which it will
be determined whether or not the grounds on which the authorisation
was initially issued remain valid. Without regular review periods,
the momentum for the innovation of safer alternatives will be
lost.
Therefore, Article 55(d) should be amended as
follows:
(d) review periods for certain all uses.,
if appropriate.
6. TRY
TO ENSURE
PROTECTION FROM
CHEMICALS IN
IMPORTED PRODUCTS
WWF is extremely concerned that the current
proposal will allow unregistered, dangerous, or banned chemicals
to be brought into Europe from "outside" the REACH system,
through import in consumer articles. WWF believes that importers
should have the duty to ensure that all the chemicals in articles
/ products they import comply with any restrictions on use and
are registered in the EU; if not, then they (or their supplier)
should apply to register the chemicals contained in them. WWF
proposes that importers of articles be required to register under
REACH any unregistered chemicals imported by them in quantities
of 1 tonne per annum or more. The commission proposal proposes
a registration requirement based on tonnage imported per article
and intended (Article 6.1) or known (Article 6.2) release of a
dangerous chemical; WWF considers that tonnage per importer, without
consideration of the release or known dangers of the chemical
concerned, will offer better protection and be more workable.
Without such an amendment, there will be a continued
threat to health and the environment and the competitiveness of
specific industry sectors will also be threatened. Importers of
consumer products must have the same duty to register their chemicals
as importers of substances and preparations. In reality, this
will normally only require importers to specify to their suppliers
that they must use chemicals that have been registered under REACH,
as in most situations a registration will already have occurred
within the EU.
Article 6 should therefore be amended as follows.
WWF's proposed additions are shown in italic text:
Article 6 (General obligation to register substances
in articles)
1. Any producer or importer of articles
shall submit a registration to the Agency for any substance contained
in those articles, if:
it is present in those articles in quantities
in a cumulative quantity totalling over 1 tonne per producer
or importer per year (each article type shall be considered separately);
and
it meets the criteria for classification as
dangerous in accordance with Directive 67/548/EEC; and
it is intended to be released during normal
and reasonably foreseeable conditions of use.
2. Any producer or importer of articles
shall notify the Agency of any substance
contained in those articles in accordance with
paragraph 3, if:
it is present in those articles in quantitites
totalling over 1 tonne per producer or importer per year; and
it meets the criteria for classification as
dangerous in accordance with Directive 67/548/EEC; and
the producer or importer knows, or is made known,
that the substance is likely to be released during normal and
reasonably foreseeable conditions of use, even though this release
is not an intended function of the article; and
the quantity of the substance released may adversely
affect human health or the environment.
2. Paragraph 1 shall not apply to substances
that have already been registered for that use by an actor up
the supply chain.
3. Paragraph 1 shall apply 3 months after
the appropriate deadline specified in Article 21, based on the
cumulative tonnage of substance imported.
4. Legislation for the implementation
of this Article may be adopted in accordance with the procedure
referred to in Article 130 (3).
3. If the conditions in paragraph 2 are
met, the information to be notified shall include the following,
in the format specified by the Agency in accordance with Article
108:
(a) his identify and contact details;
7. REGISTRATION
DATA SHOULD
BE INDEPENDENTLY
AUDITED
There is currently no mandatory evaluation of
the quality and content of the registration dossiers, as the Chemicals
Agency will only check for completeness (Article 18(2)). Given
that a recent evaluation by Competent Authorities of Member States
found that only 25% of safety data sheets were fully accurate,
WWF considers it vital that such an audit is required in order
to ensure the accuracy of registration dossiers.
Therefore, we suggest that the following should
be added to Article 5 (General obligation to register substances
on their own or in preparations):
All submissions for registration should be
independently audited prior to their submission to the Agency,
and the audit report should be submitted to the Agency with the
submission for registration. This audit should ensure that the
registration is complete and reasonable. The audit should be carried
out by an organisation independent of the registrant, although
the costs should be met by the registrant. The Agency will formulate
guidance on such quality audits.
8. STRENGTHEN
MEASURES TO
MINIMISE ANIMAL
TESTING BY
REQUIRING ONE
REGISTRATION PER
CHEMICAL TO
AVOID DUPLICATION
OF TESTS
The Commission has included financial and other
incentives to encourage data sharing at registration, but we feel
that data sharing must be made compulsory to ensure duplicate
animal testing is avoided. Thus, the current REACH proposal allows
companies producing or importing the same chemical to register
separately, and does not oblige companies to share safety data
on the chemical. This will lead to unnecessary animal and other
tests. WWF recommends one registration per chemical, which should
be achieved by amendments to the legislation making it compulsory
for industry to form consortia.
We have not supplied proposed text to deliver
this, as we are aware that it is already a key thrust of the UK
Government's position.
9. SECURE
THE RIGHT
TO KNOWAND
LIMIT COMMERCIAL
CONFIDENTIALITY
CLAIMS
Public access to all toxicity, fate, exposure,
use categories and risk assessment data should be ensured. Thus,
the full registration dossier and the chemical safety report for
each chemical should be publicly available, as should information
on total production/import volumes, at least on a banded basis.
This information should be made available and put on a publicly
accessible data-base on the internet within a specified time period.
The proposed procedure to access chemical safety
information is cumbersome and ineffective. There should be a presumption
of access, and an accessible appeal mechanism to challenge secrecy
claims. The envisaged appeal mechanism outlined below is in line
with text in the Aarhus Convention. Article 115.1 and 2 (Access
to information) should be replaced with the following text:
1. A registrant, downstream user, applicant
or other party concerned may indicate the information which they
consider to be commercially sensitive and disclosure of which
might harm him commercially and which he therefore wishes to be
kept confidential from all persons other than the competent authorities,
the Agency and Commission. He shall give a full justification
in each case.
2. Requests for confidentiality within
the terms of paragraph 1 shall be considered by the Agency responsible
for registration or authorisation, or, in the case of an evaluation
by the competent authority of the appropriate Member State. The
relevant authority shall decide which requests shall be granted
or denied on the basis of justification.
3. Where a person or authority is denied
access to information which has been declared confidential, each
Member State shall ensure that there is access to an expeditious
procedure established by law that is free of charge or inexpensive
for reconsideration by a public authority or review by an independent
and impartial body other than a court of law.
The list of information that should not be considered
confidential needs to be extended to ensure that basic information
about risks is directly made available to business and the general
public, where there is no genuine reason for claiming confidentiality.
There is a range of information where there is no convincing argument
for how they could be considered as confidential, including the
ingredients of preparations (on a qualitative but not quantitative
basis), total production tonnage, use categories and exposure
assessments. Article 116 (Confidentiality), which lists in paragraph
(1) the information that shall not be considered as confidential
should be extended by adding:
the name of the registrant;
chemical structure(s) of the substance;
the total volume of a substance
in the EU market based on volume groups;
list of ingredients in preparations.
10. Ensure sufficient hazard data on
chemicals is provided to enable good risk management decisions
Industry should be required to provide sufficient
toxicity data on all their chemicals in order to enable good risk
management decisions to be taken, with regard to both environmental
and human health. In particular, it is crucial that enough information
is provided to identify those chemicals of very high concern.
However, WWF is concerned that the draft REACH
text has been significantly weakened as compared to the internet
text with regard to the data required for the chemicals traded
in volumes of 1-10 tonnes. In order to identify those that require
authorisation, there is at least a need to get robust information
on the persistence of the chemical, and therefore there is a need
to re-instate the test on biodegradation.
There is also a need to ensure that the information
requirements for isolated intermediates are adequate to ensure
proper risk management. Once these substances are isolated from
the reaction vessels and transported either on site or to several
different sites, then significant exposure may occur, such that
the health and environmental effects of isolated intermediates
should not be overlooked. Moreover, it should also be recognised
that REACH is the only legislation that can be used to obtain
data on the properties of these chemicals.
TOPICAL ISSUES:
PRIORITISATION AND
COSTS
1. Prioritisation
One of the key concerns surrounding the regulation
is how it will work in practice and what is achievable. WWF is
keen to ensure that the Regulation is both practicable and realistic
and therefore WWF supports and indeed advocates a clear prioritisation
procedure.
Prioritisation of chemicals could be undertaken
at three different places in the strategy:
1. to feed chemicals into registration;
2. to queue chemicals of concern into the
post-registration substance evaluations; and
3. to queue chemicals of very high concern
into the authorisation process.
WWF would support prioritisation in the final
stage to ensure the worst chemicals that had undergone registration
were evaluated as a priority, and to ensure that the worst chemicals
went through to the prior authorisation process first. However,
WWF does not support a risk-based prioritisation process to queue
all chemicals into the REACH registration process, or indeed,
what would be even more worrying, to determine which chemicals
should be brought under the registration process at all.
WWF considers that queuing chemicals into the
registration process on the basis of chemicals known to meet the
criteria for very high concern, and then chemicals traded in high
volumes, followed by those traded in progressively lower volumes,
provides a transparent and workable system. At present only the
known CMR chemicals of the chemicals of very high concern are
fast tracked into registration, and thus there is a need to also
fast track those meeting the PB(T) criteria into registration.
WWF disagrees with the prioritisation of chemicals
for registration on the basis of risk (which amalgamates toxicity
and exposure) because it would:
not be robustas it could only
be based on the sparse existing data;
result in a much more labour intensive
process for the regulatory authorities; and
be open to numerous challenges by
industryif chemicals with what might appear to be similar
toxicity and exposure data were prioritised differently.
Conversely, registration on the basis of volumes
traded, is a legally robust way to get all the old chemicals phased
into the system. Registration should not be seen as a risk management
action per se, but rather a safety standard that all chemicals
should fulfil.
It should be noted that the draft legislation
released in October did address the prioritisation issue to a
certain extent, in that there were some new approaches to ensure
that resources were not diverted into initiatives seen to be of
lower priority. For example, the new text only requires Chemical
Safety Reports (CSRs) for chemicals traded in volumes of over
10 tonnes. Moreover, safety data sheets rather than CSRs are now
seen to provide an adequate way of passing information to downstream
users.
2. Costs and benefits of the regulation
Impacts on Industry
WWF fully recognises the need to ensure the
competitiveness and sustainability of the EU chemical industry.
However, WWF rejects the arguments that REACH will be economically
damaging.
The Commission's extended impact assessment
shows[9],
the direct costs will be around
2.3 billion (
1.9-
3.2 billion), whilst the total direct and indirect
costs (including the costs for downstream users) might range from
2.8 billion to
5.2 billion. These figures might seem large, but
they should be viewed in perspective. For example, the direct
costs of
2.3 billion amount to around just half a euro per
EU citizen per year over 11 years, or the same amount as the European
chemical industry spent on environmental improvements related
to waste in 1999 alone. Moreover, the amount of money that needs
to be spent is not unrealistic when compared to the chemical industry's
annual turnover. For example, even the worst case total direct
and indirect costs of
5.2 billion, spread over 10 yearswould only
amount to around 0.12% of the chemical industry's annual turnover,
which was estimated to be
417 billion per annum in 2000.
WWF considers that industry trade groups have
been engaged in scare-mongering tactics. For example, they have
expressed concern that current proposals for new EU wide legislation
on chemicals (REACH) will decimate Britain's chemical industry[10],
and result in "critical damage"[11].
However, a former CBI director general, Adair Turner destroyed
industry's arguments that REACH will lead to a decline in the
EU chemicals sector. In his new book, "Just Capital"
he states, "There is no evidence that increasing environmental
constraints have slowed overall growth rates, and no evidence
that higher environmental standards in some developed countries
have disadvantaged them economically versus others."[12]
Impact on Jobs
Industry has also played on the fears of workers
by highlighting the threat to jobs. This has been spearheaded
by a report commissioned by the Federation of German Industries
(BDI) conducted by consultants Arthur D Little. This report predicted
job losses of between 150,000-2,350,000 in the German manufacturing
industry[13].
A similar French study, by Mercer Management Consulting, forecast
a loss of GDP in France and cumulative job losses in all business
sectors of between 360,000 and 670,000 overall. However, the BDI
study was severely criticised by a group of leading German economists,
drawn together by the German Environment Agency. These expert
economists considered that the BDI report conclusions were unsupportable.
For example, it wrongly assumed chemicals would leave the market
and that no substitutes would be found in spite of substantial
need downstream, such that it did not take into proper account
the positive economic effects of REACH, that is the impetus to
innovation[14].
Moreover, the financial costs put forward in the BDI report did
not take into account the savings made from using existing data.
Nevertheless, despite this expert criticism, on the 16 September
2003, the BDI released an update of their study, based on the
same flawed methodology. This time they predicted, based on the
internet consultation text, that current proposals would cost
the German economy 4.7% gross value added, and would translate
into a loss of 1,735,000 jobs[15].
Several studies show that these worries are
not well-founded. The world famous economist, Professor David
Pearce OBE, has highlighted the lack of impact on employment of
environmental legislation. A report by Pearce and Koundouri has
concluded that "there is little evidence that environmental
regulations have significant effects on employment", and
"we know of no evidence to suggest that firms relocate in
response to environmental regulation. Other costs are far more
important to locational decisions than regulatory compliance costs."[16]
Furthermore, even the chemical industry itself
has acknowledged that stringent regulation is not the main reason
companies re-locate in other countries. According to the CBI a
survey shows "labour costs are the main reason UK firms relocate
overseas. Fifty five per cent of firms that have moved or are
considering moving abroad said labour cost was the most important
factor."[17]
Other research confirms that the jobs versus
the environment arguement just does not stack up. In the USA,
States that fail to protect their environment don't do well, whereas
States that enact strong environmental protection tend to create
good jobs, spread the wealth around more fairly, have better public
health, fairer taxes, and greater democratic participation[18].
Therefore, the doomsday predictions that REACH
will cause companies to re-locate outside Europe do not appear
valid. In order to trade within the EU, companies based outside
will still have to comply with certain provisions of this legislation,
and the EU is an important growing market which companies will
not want to ignore.
Whilst, it can be predicted that REACH will
cause a decline in jobs making chemicals of very high concern,
it should not be forgotten that it will also stimulate the creation
of new jobs making safer chemicals.
Benefits
The benefits of the new REACH legilsation, include
the benefits to innovation, as well as the environmental and health
benefits that will result from better knowledge of the effects
of chemicals and hence better risk management.
Business benefits
The European Commission extended impact assessment
notes the many benefits that REACH will bring to innovation. For
example:
for new chemicals the testing threshold
has been raised from 10 kilograms per year to 1 tonne per year;
substances manufactured for product
and process orientated research are exempt from registration for
a period of five years (renewable for an additional five years);
there is now a level playing field
for new and existing chemicals, rather than existing chemicals
being favoured.
A report on innovation from SPRU at Sussex university[19],
commissioned by WWF UK, has underlined that "the negative
impacts on innovation, competitiveness and employment have been
overstated in industry-funded studies, and that insufficient account
has been taken of broader social and environmental benefits."
Other methodological problems with industry studies are also highlighted,
"especially the absence of a sound treatment of innovation,
and problems related to the changing nature of costs and benefits."
Another report by environmental groups has similarly
noted that the REACH Regulation may bring many benefits to business,
including new markets for safer and more environmentally friendly
products, reduced risk of future liability lawsuits, easier introduction
of new chemicals, a more predictable regulatory system, and improved
transparency and communication through the supply chain, leading
to increased influence and confidence for downstream users and
SMEs[20].
Health Benefits
Perhaps most importantly, REACH will also provide
health benefits both for the public at large and for workers.
In the EU, dangerous substances currently contribute significantly
to the 350 million days lost through occupational ill health,
and to the seven million people suffering from occupational illnesses.
For example, some 32 million employees are exposed to carcinogenic
agents. Moreover, it should be recognised that it is not just
workers in the chemical industry who are at risk, the jobs at
highest risk include: hairdressers, garage mechanics, and printers[21].
Allergy costs alone are estimated at
29 billion/year in Europe[22].
Chemical substances are considered to play a major role in inducing
allergies either directly or by increasing susceptibility to natural
allergens (eg pollen). For example, a US study has shown that
asthma cases have risen by 40% since the 1970s. If the new strategy
makes even a small reduction in the
29 billion of allergy costs, this will outweigh the
direct costs of the strategy[23].
However, the social costs of allergy in Europein terms
of health care and absenteeism, may be greater, with another estimate
suggesting
45 billion per year[24].
Annually, in Britain alone it is estimated that:
some 6,000 cases of cancer are considered
to be occupationally caused;
there may be up to 7,000 new cases
of asthma which are either occupationally caused, or have work
as a significant contributing cause[25].
(And around 1500 new cases of occupational asthma annually are
seen by specialist chest and occupational physicians[26]);
and
each year 39,000 people suffer from
a new or existing work-related skin disease."[27]
Thus, although there is existing Occupational
Health and Safety legislation to control chemicals, evidence from
ill health statistics and experience from existing chemical schemes
indicates gaps in the current control regime. The costs of occupational
asthma alone have been estimated in the UK at between £500
and £1,000 million over the next 10 years (recent RIA for
asthmagens AcoP)[28].
Quite apart from the mortality rates, morbidity rates at these
levels represent a high proportion of the totality of work related
ill health and therefore the number of work days lost.
The requirement to use safer substitutes may
often save costs in the long-term. For example, it is relatively
easy to see when an NHS trust is required to pay substantial compensation
to staff sensitised by latex or glutaraldehyde, how much cheaper
it would have been to substitute with a safer alternative or ensure
effective control of exposure[29].
The new legislation should provide an impetus to producing and
using safer substances, and may therefore save money in many situations.
Professor David Pearce, and Phoebe Koundouri,
estimated the health benefits of the internet text of May 2003[30].
Various scenarios were costed and the authors confidently concluded
that the health benefits of the REACH regulation outweigh the
predicted costs. Indeed, they suggested that the European Union
could be a staggering
260 billion euros (180 billion pounds) better off,
even after taking into account the costs to businesses of implementation.
In just the UK, these authors estimated that the savings in health
expenditure could be around
74.9 billion (50 billion pounds). However, it should
be noted that these estimates relate to the May internet text,
which has now been watered down in draft Regulation of October
2003, such that both the benefits and costs portrayed in this
report will have been reduced.
With regard to the final draft REACH legislation
as of October 2003, the Commission in its extended impact assessment
attempted to estimate the health benefits for the whole population.
This estimate was based on a World Bank study which suggested
that in established market economies, pollution from agro-industrial
chemicals and diffuse sources causes between 0.6%-2.5% of the
total disease-burden (that is deaths and general ill health).
However, another estimate suggests that the World Bank may have
underestimated the burden of disease environmentally attributable
by 150%. Nevertheless, the Commissions uses this World Bank study
as a starting point and argues for a conservative figure of 1%,
and then assumes that the proportion of this disease that will
be identified and tackled by REACH will be 10%, implying that
90% of health impacts associated with chemicals are either related
to historical exposures, or will not be identified by REACH, or
cannot be tackled. These figures therefore suggest that 45,000
DALYs (Disability Adjusted Life Years) will be avoided each year
due to REACH. Assuming 10 DALYs are equivalent to one life saved,
then 45,000 DALYs would be equivalent to 4,500 lives saved. This
methodology was extended to predict that 10 years after implementation,
positive effects on public health would result, to the tune of
around 50 billion euros, although this should not be seen as a
robust estimate of the benefits, rather an illustration of their
potential scale. Nevertheless, again it can be predicted that
the costs will be far out-weighed by the benefits.
With regard to the benefits for wildlife, although
chemicals are known to have affected numerous avian and other
wildlife species, it is impossible to quantify the potential benefits
of REACH. However, a report by the independant research group,
RPA, has looked at some case studies to see whether REACH is likely
to deliver environmental and general public safety benefits. It
concludes that had REACH been in place, the damage from the use
of each of the case study chemicals could have (and most proably
would have) been reduced earlier. It therefore identified several
key advantages of REACH over the current system. It concludes
that REACH (i) by assessing the properties of substances, and
thereby making information available more quickly, has the potential
to identify a hazard before (substantial) damage occurs, rather
than waiting for monitoring (which is slow and under-funded) to
provide evidence of harm; (ii) provides a basis for quicker regulatory
action for the most hazardous substances (through accelerated
risk management and authorisation)[31].
Certainly, nothwithstanding the incalculable
damage to wildlife, the improper use and disposal of chemicals
can lead to sustantial costs in terms of the clean-up of contaminated
land, and other restoration costs.
Therefore, overall WWF confidently predicts
that the costs of REACH will be far outweighed by the benefits
both quantatively and qualitatively.
THE ROLE
PLAYED BY
THE UK GOVERNMENT
At the Chester meeting during the UK's presidency
in 1998, the UK took an important role in co-ordinating several
Member States to release a landmark statement, which highlighted
the need to develop new and better legislation to control chemicals.
This led to the eventual development of the REACH legislation.
The UK continues to be a powerful positive force for change and
it is vital that the Government uses this force and its leverage
within Europe to assure the success of this important piece of
legislation.
WWF is grateful for the priority assigned to
progressing this legislative proposal over the following years.
Defra, as lead department, has invested much time, effort, and
expertise, in co-ordinating the views amongst the different Government
departments, and in synthesising the views of different stakeholders.
It is now vital that the current lead Minister, the Rt Hon Alun
Michael MP, engages fully with this important but complex regulation
and continues to steer the UK Government towards a strong position
on the Regulation. Most importantly it is vital that Defra resists
capitulating to industry's demands.
However, WWF has been disappointed by the lack
of support given to the new legislation by HSE. It is a well-known
fact that the vast majority of substances traded in the EU do
not have available adequate toxicity data to make even a basic
risk assessment. Legislation which requires such information,
and which requires this information to follow the chemical up
and down the supply chain, must make for better decisions on where
to invest more effort to protect worker health. But there appears
to be little enthusiasm on the part of HSE to support this legislation
or to take an active role in the implementation of the REACH legislation.
In order to address this apathy, it is vital that adequate resources
for the UK regulatory authorities must be available to implement
the legislation. Without the allocation of adequate resources
in the Member States to oversee implementation, including adequate
resources for substance evaluation, this legislation will flounder.
Given the clear benefits that this regulation could bring to public
health, it is also lamentable, that Department of Health has not
taken a visible supporting role.
However, WWF is more concerned about the DTI's
increasingly pro-industry hard line against the Regulation whilst
downgrading the importance of a robust Chemical Regulation for
the benefit of humans and wildlife. The Secretary of State for
Trade and Industry, the Rt Hon Patricia Hewitt commented that
the proposed Chemical Regulation was "disastrously wrong"[32]
and would move firms off shore. Such an idea in our view is both
misinformed and completely unfounded.
Further evidence that the UK is prioritising
the concerns of a dinosaur industry over and above the needs of
human health, came when the Prime Minister signed up to a joint
letter to Commissioner Romano Prodi urging the EU to substantially
change the chemical proposals, to ensure not to place unnecessary
burdens on industry (see Appendix 1).
WWF is aware that the chemicals legislation
may become an expendable pawn in a larger political picture, for
example, perhaps in exchange for support on Iraq or to appease
the concerns of the Bush administration. The USA is mounting an
intensive campaign to try to reduce the need for all chemicals
to have safety data before they are traded. We attach to this
briefing a letter sent by the US Secretary of State, Colin Powellshowing
that the Bush administration has pushed for the legislation to
focus on fewer chemicals, and has stressed the concerns with regard
to international trade (see Appendix 2).
The UK government should be leading the way
by supporting a robust Chemical Regulation, which protects future
generations of humans and wildlife. A tough regulation, which
encourages phase out of the most hazardous chemicals will be good,
not only for humans and wildlife, but for business and innovation
too. It will provide an improved framework for innovation in the
chemicals sector, and contribute to the development of green chemicals.
It could strengthen the competitiveness of the chemicals industry
and provide new markets for safer and more environmentally friendly
products. This is a key chance for the UK Government to promote
the development of our chemicals industry and to grasp this opportunity
for greater innovation, competitiveness and consumer choice.
WWF considers that it is vital that this legislation
is not emasculated, because doing so would significantly reduce
the benefits to health and the environment, and yet still give
rise to considerable costs.
In future, we therefore urge the UK Government:
to prioritise the needs of public
health, our wildlife and the environment;
to recognise the business, health
and environmental benefits of the EU Chemical Regulation;
to clearly commit to a robust chemical
regulation which incorporate the substitution principle and phases
out the most harmful chemicals where safer alternatives exist;
and
use its leverage within the EU to
push other key member states to support a similarly robust position.
Only by taking leading by example and show a
clear preference of the health of future generations will the
UK Government reap the full benefits of this once in a lifetime
opportunity.
December 2003
3 Here WWF defines the word available in a similar
way as it is defined in the IPPC Directive, such that it is an
alternative which is reasonably accessible and that has been developed
on a scale which allows its implementation as a substitute, under
economically and technically viable conditions. Back
4
Page 8, para 5; European Commission, White Paper: Strategy for
a future Chemicals Policy. 2001, Commission of the European Communities:
Brussels, Belgium. European Commission, http://www.europa.eu.int/comm/environment/chemicals/whitepaper.htm
"Another important objective is to encourage the substitution
of dangerous by less dangerous substances where suitable alternatives
are available." Back
5
Point 49; European Parliament, European Parliament resolution
A5-0356/2001on the Commission White Paper on Strategy for a future
Chemicals Policy (COM(2001) 88-C5-0258/2001-2001/2118(COS)). 2001,
European Parliament: Brussels. European Parliament. Back
6
Point 15; Environment Council, Strategy for a future chemicals
policy: COUNCIL CONCLUSIONS. 2001, Environment Council: Brussels,
Belgium. Environment Council, http://europa.eu.int/comm/enterprise/chemicals/chempol/whitepaper/councconcl.htm
"Chemicals that are dangerous should be substituted with
safer chemicals or with safer alternative technologies not entailing
the use of chemicals." Back
7
Doc XI/14168/99-Industry's response, introduced by CEFIC, regarding
the UK Rapporteur's Proposal at TM III `99 on pentabromodiphenyl
ether. This states "when putting this whole breast milk issue
into perspective, industry believes that the only rational and
scientific conclusion that can be drawn is a conclusion ( ii )"
A conclusion (ii) means that there is no need for further information
and/or testing and no need for risk reduction measures beyond
those which are being applied already. Back
8
Directive 2003/11/EEC. Back
9
Commission staff working paper (2003) Extended impact assessment
SEC 1171/3 Brussels, 29/10/2003. Back
10
See CBI (Confederation of British Industry) (2003). CBI steps
up fight over EU Chemicals Law, 8 August 2003. Back
11
See CIA (Chemical Industries Association) (2002). CIA welcomes
German report on impact of EU chemicals policy, 18th November
2002. Back
12
Adair Turner (2003). Just Capital. Macmillan. Back
13
CIA (2002). CIA welcomes German report on impact of EU chemicals
policy, 18 Nov 2002. Back
14
See Environment Daily 1402, 11/03/03. Also see:- German Environment
agency http://www.umweltbundesamt.de/ tel: +49 30 89030 Summary
of conclusions of meeting http://www.umweltbundesamt.de/uba-info-presse/hintergrund/stoffpol.htm
and press release http://www.umweltbundesamt.de/uba-info-presse/presse-informationen/pd01703.htm Back
15
Arthur D Little (BDI update) (2003). Economic Effects of the
EU Substances Policy, Supplement to the Report on the BDI* Research
Project 18th December 2002, dated 31 August 2003. Back
16
Pearce and Koundouri (2003). The social cost of chemicals:
The Costs and Benefits of Future Chemicals Policy in the European
Union, A report to WWF-UK, May. Back
17
The full release can be found at: http://www.cbi.org.uk/ndbs/press.nsf/0363c1f07c6ca12a8025671c00381cc7/b4efb12492e2b4d180256d8f004180ff?OpenDocument Back
18
See Rachel's Environment and Health News, Number 881. http://www.rachel.org
For research details see:- Templet, Paul H. (2001). Defending
the Public Domain: Pollution, Subsidies, and Poverty [PERI
Working Paper No. DPE-01-03]. Amherst, Mass.: University of Massachusetts,
Amherst, Political Economy Research Institute. Available at: http://www.umass.edu/peri/pdfs/WP12.pdf
. Pastor, Jr, Manuel. 2001. Building Social Capital To Protect
Natural Capital: The Quest for Environmental Justice PERI
Working Paper No. DPE-01-02]. Amherst, Mass.: University of Massachusetts,
Amherst, Political Economy Research Institute. Available at: http://www.umass.edu/peri/pdfs/WP11.pdf
. Back
19
Berkhout F, Iizuka M, Paul Nightingale P, and Georgina Voss G
(2003). Innovation in the chemicals sector and the new European
Chemicals Regulation. A report for by researchers from Science
and Technology Policy Research (SPRU) at Sussex University, WWF
UK, Godalming. Back
20
WWF EPO and EEB (2003). Discussion paper. A new chemicals
policy in Europe-new opportunities for industry: A response
to the claims made regarding the business impact of a new chemicals
policy that is designed to protect the environment and human health.
January 2003 http://www.panda.org/downloads/europe/wwfeebreachnewopforindustry.pdf Back
21
Diamantopoulou Anna (2003). A speech at the launch of European
Week 2003 on Dangerous Substances-by the European Commissioner
responsible for employment and social affairs. Strasbourg, 13
May 2003. Back
22
German Advisory Council on the Environment-1999 figures. Back
23
Commission of the European Communities: White Paper-Strategy
for a future chemicals policy, 27 February 2001. Annex 1. Back
24
RTD Info: Magazine for European Research, 29 April 2001. see
http://europa.eu.int/comm/research/rtdinfo/pdf/rtd29-en.pdf Back
25
Paper presented to the Advisory Committee on Toxic Substances.
HSE's chemical strategy, ACTS/20/2002, 78th Meeting 22/23 July
2002. Back
26
Paper presented to the Advisory Committee on Toxic Substances.
HSC/02/106 by John Thomas. Meeting date 12 November 2002. Back
27
HSE, See web page entitled "Dermatitis and other skin disorders"
survey SW102 http://www.hse.gov.uk/statistics/causdis/skin.htm.
This figure is derived from the self-reported work related illness
survey and updates an earlier figure of 66,000 of which 44,000
cases were estimated to be occupational dermatitis. However, differences
in the methodology between this and the earlier survey (SW195)
mean they are not really comparable, so it would be inappropriate
to infer a real reduction in the prevalence of occupational skin
disease (pers.comm. Ryan M (2003). Email from HSE dated 11 September). Back
28
Paper presented to the Advisory Committee on Toxic Substances.
HSC/02/143 by Mark Blainey. Meeting 12 November 2002. Back
29
Paper presented to the Advisory Committee on Toxic Substances.
Tackling Occupational Asthma, ACTS/05/2003 by Donald Adey. Meeting
13 March 2003. Back
30
Pearce D and Koundouri P (2003). The social cost of chemicals:
The Costs and Benefits of Future Chemicals Policy in the European
Union, A report to WWF-UK, May. Back
31
RPA and BRE Environment (2003). The Impact of the new chemicals
policy on health and the environment. Final report-prepared
for the European Commission Environment Directorate General. Contacts:
post@rpa.td.demon.co.uk and brookedn@bre.co.uk Back
32
Jean Eaglesham, Political Correspondent, Financial Times, 17
September 2003. Back
|